The information you provide to us for this Free Case Evaluation will be treated as strictly confidential. You will get a reply from us no later than the next business day. Submitting a case evaluation does not obligate you to hire our law firm for your lawsuit. We handle all cases on a contingency fee basis, which means that you will make no payment for our legal services until after we have succeeded in getting legal compensation for you.
My Articles About Fosamax
Merck Corporate SEC Filing for First Quarter 2014 Provides Information About Numbers Of Lawsuits In Various Court Jurisdictions Being Worked Up For Some Possible Trials In The Future
SUMMARY: From the Merck SEC Form 10-Q for the quarterly period ended March 31, 2014, we have our first 2014 update from Merck on the Fosamax – femur fracture litigation.
For the New Jersey Fosamax Multicounty Litigation, we want to report that the case Unanski v. Merck, which had been scheduled for trial back in March 2014, was postponed for reasons have to do with the trial court Judge, Carol Higbee, being elevated to a New Jersey appellate court position on short notice. It is uncertain at the present time when the Unanski case will be rescheduled for trial.
As we have been doing, we will continue to monitor the Fosamax – femur fracture litigation and report significant developments as they become publicly available.
Earlier Fosamax articles by Tom Lamb on the Drug Injury Watch blog:
Drug Injury Watch: September 2011: Two FDA Advisory Committees Will Discuss The Safety Of Long-Term Use Of Fosamax, Boniva, And Actonel
Drug Injury Watch: Next Fosamax Jaw Injury Lawsuit Trial, Secrest v. Merck, Scheduled To Start In Early September 2011
Drug Injury Watch: Fosamax MDL Litigation Update - May 2010: Maley Case Trial Verdict Goes In Favor Of Merck
Drug Injury Watch: More About A "New" Fosamax Bone Side Effect, Leg Fractures In Region Of Thigh Or Femur